glp 1 drugs breastfeeding GLP-1 and Breastfeeding: Safety Evidence and Clinical Consider... – PlexusDx glp 1 meds and breastfeeding
Description
Safe alternatives include metformin, SGLT2 inhibitors (empagliflozin, dapagliflozin), DPP-4 inhibitors (sitagliptin, linagliptin), and exenatide immediate-release or lixisenatide, which do not carry thyroid cancer warnings
Wright AK, et al
In the SURMOUNT-1 and SURMOUNT-3 trials, a high dose of tirzepatide (15 mg), administered subcutaneously once a week, led to approximately a 20% reduction in body weight among non-diabetic adults with a BMI 27 kg/m 2 after two years of treatment [142, 143]
Potential Benefits of GLP-1 RAs Known for their metabolic benefits, emerging studies suggest GLP-1 RAs may help improve kidney function, cardiovascular health, non-alcoholic fatty liver disease, Alzheimer's disease and Parkinsons disease
[DOI] [PubMed] [Google Scholar] 248.Sugiyama K., Manaka H., Kato T., Yamatani K., Tominaga M., Sasaki H
Lilly is studying retatrutide across obesity, type 2 diabetes, cardiovascular risk, and related conditions
